Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
May 28, 2024 - The FDA approved Amgen’s Bkemv (eculizumab-aeeb), biosimilar and interchangeable to AstraZeneca’s Soliris® (eculizumab).
Download PDF
Return to publications
